Invention Grant
![Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide](/docs/US/2022-03-15/US11273126B2/abs.jpg.600x600.jpg)
- Patent Title: Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide
-
Application No.: US16494598Application Date: 2018-03-15
-
Publication No.: US11273126B2Publication Date: 2022-03-15
- Inventor: Yashoraj Zala , Bramhanand Hanamannavar , Nitin Dharmadhikari
- Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
- Applicant Address: IN Maharashtra
- Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
- Current Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
- Current Assignee Address: IN Maharashtra
- Agency: Paratus Law Group, PLLC
- Priority: IN201721005409 20170315
- International Application: PCT/IN2018/050147 WO 20180315
- International Announcement: WO2018/167803 WO 20180920
- Main IPC: A61K9/16
- IPC: A61K9/16 ; A61K9/00 ; A61K31/44
![Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide](/abs-image/US/2022/03/15/US11273126B2/abs.jpg.150x150.jpg)
Abstract:
An oral, solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion.
Public/Granted literature
Information query
